IDH2 and colorectal cancer: Given that the accumulation of 2-HG from mutant IDH1/IDH2 is a key inducer of EMT, and that knockdown of IDH1 in mutant IDH1-overexpressing HCT116 colorectal cancer cells could reverse the EMT phenotype, targeting mutant IDH to prevent 2-HG production has been considered [177].